FDA rejects MDMA as treatment for PTSD

The FDA rejected MDMA as a treatment for post-traumatic stress disorder last Friday, amid strong opposition by an agency scientific advisory committee in June and allegations of missing adverse event data and research bias. See also: 3 MDMA therapy papers retracted and FDA was right.